Russian Journal of AllergyRussian Journal of Allergy1810-88302686-682XFarmarus Print Media147910.36691/RJA1479Review ArticleVaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical ImmunologyIlyinaNatalya I.<p>MD, Dr. Sci. (Med.), Professor</p>instimmun@yandex.ruhttps://orcid.org/0000-0002-3556-969XKurbachevaOksana M.<p>MD, Dr. Sci. (Med.), Professor</p>kurbacheva@gmail.comhttps://orcid.org/0000-0003-3250-0694LatyshevaElena A.<p>MD, Dr. Sci. (Med.)</p>ealat@mail.ruhttps://orcid.org/0000-0002-1606-205XLatyshevaTatiana V.<p>MD, Dr. Sci. (Med.), Professor</p>tvlat@mail.ruhttps://orcid.org/0000-0003-1508-0640NazarovaEvgeniya V.<p>MD, Cand. Sci. (Med.)</p>ev.nazarova@nrcii.ruhttps://orcid.org/0000-0003-0380-6205NenashevaNatalia M.<p>MD, Dr. Sci. (Med.), Professor</p>1444031@gmail.comhttps://orcid.org/0000-0002-3162-2510FedenkoElena S.<p>MD, Dr. Sci. (Med.), Professor</p>efedks@gmail.comhttps://orcid.org/0000-0003-3358-5087KhaitovMusa R.<p>MD, Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences</p>mr.khaitov@nrcii.ruhttps://orcid.org/0000-0003-4961-9640ShartanovaNatalia V.<p>MD, Dr. Sci. (Med.)</p>nshartanova@yandex.ruhttps://orcid.org/0000-0002-1197-9002National Research Center — Institute of Immunology Federal Medical-Biological Agency of RussiaMoscow State University of Medicine and Dentistry named after A.I. EvdokimovNational Research Center – Institute of Immunology Federal Medical-Biological Agency of RussiaPirogov Russian National Research Medical UniversityRussian Medical Academy of Continuous Professional Education0610202118393970509202106092021Copyright © 2021, Pharmarus Print Media2021<p>One of the key tasks of the previous year is to stop the spread of coronavirus disease (COVID-19), which became a pandemic that led to the deaths of more than 4 million people worldwide and more than 140 thousand deaths in Russia. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (2019-nCoV) virus of the coronavirus family. Vaccination plays a leading role in ending the pandemic. Currently, five vaccines against COVID-19 have been registered in Russia, namely, Sputnik V, Sputnik light, EpiVacCorona, EpiVacCorona-Н, and СoviVak. The short follow-up period and absence of randomized placebo-controlled trials of COVID-19 vaccines in certain patients with chronic diseases lead to several questions about the effectiveness/safety of vaccination in these patients. Given the wide spread of allergic diseases and the heterogeneity of patients with allergopathology, experts of the Russian Association of Allergology and Clinical Immunology have developed and approved a position paper on vaccination of patients with allergopathology.</p>COVID-19vaccinationcoronavirusallergopathologyallergic diseasesclinical guidelinesCOVID-19вакцинациякоронавирусаллергопатологияаллергические заболеванияклинические рекомендации[World Health Organization. Coronavirus disease (COVID-19) pandemic. (In Russ). Available from: https://www.who.int/. Accessed: Aug 15, 2021.][American Academy of Allergy, Asthma & Immunology. Allergen immunotherapy and COVID-19/SARS-CoV-2 vaccination. (In Russ). Available from: https://www.aaaai.org/Allergist-Resources/Ask-the-Expert/Answers/Old-Ask-the-Experts/allergenimm. Accessed: Aug 15, 2021.][American Academy of Allergy, Asthma & Immunology. COVID vaccine reaction in a patient with asthma. (In Russ). Available from: https://www.aaaai.org/Allergist-Resources/Ask-the-Expert/Answers/Old-Ask-the-Experts/covidvreac. Accessed: Aug 15, 2021.][Global Initiative for Asthma. GINA guidance about COVID-19 and asthma, updated 30 March 2021. GINA Global Strategy for Asthma Management and Prevention. (In Russ). Available from: https://ginasthma.org/wp-content/uploads/2021/03/21_03_30-GINA-COVID-19-and-asthma.pdf. Accessed: Aug 15, 2021.][Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112(4):815–820. doi: 10.1542/peds.112.4.815][Jutel M, Torres MJ, Palomares O, et al. COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics ― EAACI recommendations. Authorea. June 24, 2021. doi: 10.22541/au.162452341.15060228/v1][Klimek L, Bergmann KC, Brehler R, et al. Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe: Ein Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA), der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) und der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI). [In German] Allergo J. 2021;30(3):22–43. doi: 10.1007/s15007-021-4773-1.][The procedure for vaccination of the adult population against COVID-19. Temporary methodological recommendations. Moscow; 2021.]